Overview

Multi-Center Study of Different Doses Domperidone in Feeding Intolerance

Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this clinical multi-center study is to determine whether different doses of domperidone are effective in the treatment of feeding intolerance in premature infant
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Nanfang Hospital of Southern Medical University
Collaborators:
Guangdong Provincial Maternal and Child Health Hospital
Guangzhou Panyu Central Hospital
Maternal and Child Health Hospital of Foshan
Maternal and Child Health Hospital,Huadu District
Shen-Zhen City Maternity and Child Healthcare Hospital
Treatments:
Domperidone
Criteria
Inclusion Criteria:

- the residual milk and glucose over 55%

- abdominal distention or vomiting;

- Reduce,delay or disruption of enteral feeding

Exclusion Criteria:

- Four weeks before the start of this study had participated in other clinical trials

- pulmonary hypertension;

- Infants with necrotizing enterocolitis

- Gastrointestinal tract malformation, congenital heart disease

- Pre-existing QT extend/between long QT syndrome;

- ascites

- Have been used or will use drugs suppress CYP3A4

- Other risk factors for prolong the QT